NASDAQ : LRMR
Larimar Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 278.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 22.25M | 18.87M | 18.11M | 14.49M | 12.28M | 12.07M |
| Research & Development | 156.74M | 153.62M | 72.78M | 27.27M | 24.25M | 38.40M |
| Operating Expenses | 178.99M | 172.50M | 90.89M | 41.76M | 36.53M | 50.47M |
| Operating Income | -178.99M | -172.50M | -90.89M | -41.76M | -36.53M | -50.47M |
| Other Non Operating Income (Expenses) | 6.38M | 6.82M | 10.29M | 4.81M | 1.17M | -171.00K |
| Pretax Income | -172.60M | -165.67M | -80.60M | -36.95M | -35.35M | -50.64M |
| Net Income | -172.60M | -165.67M | -80.60M | -36.95M | -35.35M | -50.64M |
| Net Income to Common | -172.60M | -165.67M | -80.60M | -36.95M | -35.35M | -50.64M |
| Shares Outstanding (Basic) | 89.63M | 72.95M | 61.26M | 43.90M | 25.76M | 17.16M |
| Shares Outstanding (Diluted) | 89.63M | 72.95M | 61.26M | 43.90M | 25.76M | 17.16M |
| EPS (Basic) | -1.93 | -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
| EPS (Diluted) | -1.93 | -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
| Free Cash Flow | -156.08M | -113.29M | -71.28M | -33.62M | -27.67M | -42.44M |
| Free Cash Flow Per Share | -1.74 | -1.55 | -1.16 | -0.77 | -1.07 | -2.47 |
| EBITDA | -178.69M | -172.15M | -90.57M | -41.45M | -36.21M | -50.14M |
| D&A For EBITDA | 301.00K | 350.00K | 318.00K | 311.00K | 318.00K | 326.00K |
| EBIT | -178.99M | -172.50M | -90.89M | -41.76M | -36.53M | -50.47M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 92.69M | 85.41M | 33.22M | 26.75M | 26.82M | 70.10M |
| Short-Term Investments | 63.58M | 51.44M | 150.24M | 60.04M | 91.60M | |
| Cash & Short-Term Investments | 156.27M | 136.85M | 183.45M | 86.79M | 118.43M | 70.10M |
| Other Receivables | 267.00K | 747.00K | 1.05M | 332.00K | 208.00K | |
| Receivables | 267.00K | 747.00K | 1.05M | 332.00K | 208.00K | |
| Prepaid Expenses | 4.14M | 4.42M | 10.80M | 3.05M | 2.31M | 1.90M |
| Total Current Assets | 160.67M | 142.02M | 195.30M | 90.17M | 120.74M | 72.20M |
| Property, Plant & Equipment | 3.69M | 2.69M | 3.72M | 3.76M | 3.69M | 4.46M |
| Other Long-Term Assets | 936.00K | 1.13M | 1.20M | 2.00M | 1.98M | 2.01M |
| Total Assets | 165.30M | 145.84M | 200.22M | 95.94M | 126.41M | 78.67M |
| Accounts Payable | 7.60M | 5.22M | 2.42M | 1.28M | 1.69M | 1.66M |
| Accrued Expenses | 25.37M | 58.47M | 20.87M | 7.39M | 8.41M | 6.59M |
| Current Portion of Leases | 1.20M | 1.10M | 1.06M | 837.00K | 611.00K | 594.00K |
| Total Current Liabilities | 34.17M | 64.80M | 24.36M | 9.51M | 10.71M | 8.85M |
| Long-Term Leases | 3.75M | 2.96M | 4.06M | 4.71M | 4.80M | 5.41M |
| Total Liabilities | 37.92M | 67.76M | 28.41M | 14.21M | 15.50M | 14.25M |
| Common Stock | 103.00K | 83.00K | 64.00K | 43.00K | 43.00K | 18.00K |
| Additional Paid-In Capital | 624.52M | 512.78M | 440.76M | 270.15M | 262.50M | 180.65M |
| Retained Earnings | -497.23M | -434.83M | -269.16M | -188.55M | -151.60M | -116.25M |
| Comprehensive Income & Other | -12.00K | 54.00K | 148.00K | 81.00K | -31.00K | |
| Shareholders' Equity | 127.38M | 78.08M | 171.81M | 81.72M | 110.90M | 64.41M |
| Total Liabilities & Equity | 165.30M | 145.84M | 200.22M | 95.94M | 126.41M | 78.67M |
| Total Debt | 4.96M | 4.07M | 5.12M | 5.55M | 5.41M | 6.00M |
| Net Cash (Debt) | 151.31M | 132.78M | 178.34M | 81.24M | 113.02M | 64.09M |
| Net Cash Per Share | 1.69 | 1.82 | 2.91 | 1.85 | 4.39 | 3.73 |
| Filing Date Shares Outstanding | 104.38M | 104.38M | 64.03M | 63.80M | 43.27M | 17.71M |
| Total Common Shares Outstanding | 104.38M | 83.34M | 63.82M | 43.91M | 43.27M | 17.71M |
| Working Capital | 126.51M | 77.23M | 170.95M | 80.67M | 110.03M | 63.36M |
| Book Value Per Share | 1.22 | 0.94 | 2.69 | 1.86 | 2.56 | 3.64 |
| Tangible Book Value | 127.38M | 78.08M | 171.81M | 81.72M | 110.90M | 64.41M |
| Tangible Book Value Per Share | 1.22 | 0.94 | 2.69 | 1.86 | 2.56 | 3.64 |
| Machinery | 2.56M | 2.42M | 2.38M | 1.86M | 1.71M | 1.61M |
| Leasehold Improvements | 93.00K | 93.00K | 45.00K | 45.00K | 31.00K | 31.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -172.60M | -165.67M | -80.60M | -36.95M | -35.35M | -50.64M |
| Depreciation & Amortization | 301.00K | 350.00K | 318.00K | 311.00K | 318.00K | 326.00K |
| Loss (Gain) From Sale of Assets | -1.00K | |||||
| Loss (Gain) From Sale of Investments | -907.00K | -1.70M | -5.26M | -1.84M | -774.00K | -14.00K |
| Stock-Based Compensation | 7.47M | 7.00M | 8.80M | 7.62M | 6.62M | 5.47M |
| Other Operating Activities | -245.00K | -281.00K | -189.00K | -82.00K | -46.00K | 15.00K |
| Change in Accounts Payable | 3.44M | 2.79M | 1.14M | -403.00K | 26.00K | -974.00K |
| Change in Other Net Operating Assets | 6.62M | 44.30M | 5.03M | -2.11M | 1.64M | 3.71M |
| Operating Cash Flow | -155.92M | -113.20M | -70.76M | -33.46M | -27.57M | -42.10M |
| Capital Expenditures | -153.00K | -91.00K | -515.00K | -164.00K | -100.00K | -333.00K |
| Investment in Securities | 55.26M | 100.40M | -84.87M | 33.52M | -90.86M | 24.50M |
| Investing Cash Flow | 55.11M | 100.31M | -85.39M | 33.35M | -90.96M | 24.17M |
| Issuance of Common Stock | 172.77M | 65.09M | 161.88M | 30.00K | 75.26M | 19.89M |
| Financing Cash Flow | 172.77M | 65.09M | 161.88M | 30.00K | 75.26M | 19.89M |
| Net Cash Flow | 71.95M | 52.19M | 5.74M | -76.00K | -43.27M | 1.95M |
| Free Cash Flow | -156.08M | -113.29M | -71.28M | -33.62M | -27.67M | -42.44M |
| Free Cash Flow Per Share | -1.74 | -1.55 | -1.16 | -0.77 | -1.07 | -2.47 |
| Levered Free Cash Flow | -94.18M | -53.47M | -42.05M | -20.84M | -14.35M | -23.09M |
| Unlevered Free Cash Flow | -94.18M | -53.47M | -42.05M | -20.84M | -14.35M | -23.09M |
| Change in Working Capital | 10.06M | 47.10M | 6.17M | -2.51M | 1.67M | 2.73M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 257.83M | 326.10M | 246.93M | 199.77M | 178.70M | 191.10M |
| Enterprise Value | 106.51M | 155.01M | 48.59M | 109.57M | 59.57M | 119.21M |
| Last Close Price | 2.47 | 3.81 | 3.87 | 4.55 | 4.13 | 10.79 |
| PB Ratio | 2.02 | 4.18 | 1.44 | 2.44 | 1.61 | 2.97 |
| P/TBV Ratio | 2.02 | 4.18 | 1.44 | 2.44 | 1.61 | 2.97 |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.03 | 0.07 | 0.05 | 0.09 |
| Net Debt / Equity Ratio | -1.19 | -1.70 | -1.04 | -0.99 | -1.02 | -0.99 |
| Net Debt / EBITDA Ratio | 0.85 | 0.77 | 1.97 | 1.96 | 3.12 | 1.28 |
| Net Debt / FCF Ratio | 0.97 | 1.17 | 2.50 | 2.42 | 4.08 | 1.51 |
| Quick Ratio | 4.58 | 2.12 | 7.58 | 9.16 | 11.06 | 7.95 |
| Current Ratio | 4.70 | 2.19 | 8.02 | 9.49 | 11.28 | 8.16 |
| Return on Equity (ROE) | -139.63% | -132.59% | -63.59% | -38.36% | -40.33% | -65.72% |
| Return on Assets (ROA) | -70.96% | -62.31% | -38.36% | -23.48% | -22.26% | -34.40% |
| Return on Capital Employed (ROCE) | -136.50% | -212.80% | -51.70% | -48.30% | -31.60% | -72.30% |
| Earnings Yield | -77.97% | -50.80% | -32.64% | -18.50% | -19.78% | -26.50% |
| FCF Yield | -60.54% | -34.74% | -28.86% | -16.83% | -15.48% | -22.21% |
| Buyback Yield / Dilution | -40.23% | -19.09% | -39.53% | -70.42% | -50.09% | -44.44% |